Regulus Therapeutics
RGLS
#7201
Rank
S$0.72 B
Marketcap
S$10.53
Share price
0.00%
Change (1 day)
430.29%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: S$0.72 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of S$0.72 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025S$0.72 B429.02%
2024S$0.13 B301.07%
2023S$34.18 M10.53%
2022S$30.92 M-50.24%
2021S$62.16 M-45.19%
2020S$0.11 B349.71%
2019S$25.21 M124.96%
2018S$11.21 M-92.25%
2017S$0.14 B-16.1%
2016S$0.17 B-73.47%
2015S$0.64 B-37.37%
2014S$1.03 B165.13%
2013S$0.39 B41.73%
2012S$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
S$144.45 B 19,721.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$47.65 B 6,438.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$156.00 B 21,305.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$350.50 B 47,993.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$124.08 B 16,925.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
S$39.54 M-94.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.84 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$25.13 B 3,349.26%๐Ÿ‡บ๐Ÿ‡ธ USA